africaprivateequitynews.com

Five notable North African private capital deals

Share Report:
Five notable North African private capital deals
Five notable North African private capital deals

We highlight five North African investments, as featured in our Dealmaker’s Log.

Jun 18, 2026∙ Paid51Share
Adenia Partners has invested in Moroccan food company Maymana.

We highlight five North African private capital transactions, as featured in our Dealmaker’s Log, a database of reported investment deals, exits, and fundraising milestones. View the latest issue here

1. Mediterrania Capital Partners in packaging deal

Mediterrania Capital Partners has signed a share purchase agreement for the acquisition of 100% of Société Marocaine des Manufactures de Mohammedia, the holding company of Amcor Flexibles Mohammedia (AFM), from Amcor Group. AFM is a Moroccan manufacturer of flexible packaging solutions, primarily serving the dairy industry, as well as the pharmaceutical, food and home, and personal care sectors.

2. Vantage Capital provides $45m mezzanine facility to Egypt’s MIDO

Vantage Capital has provided $45 million of mezzanine debt funding to the International Group for Modern Coatings (MIDO), an Egyptian manufacturer of specialty paints and coatings.

3. Adenia Partners in Morocco deal

Africa-focused private equity firm Adenia Partners has completed the first investment from its Adenia Entrepreneurial Fund I, acquiring a stake in Maymana, a brand within Morocco’s culinary sector. Maymana’s offering includes traditional Moroccan pastries, bakery and viennoiserie products, fine grocery items, and gourmet catering services.

4. Amethis MENA Fund II backs Egyptian rice-ingredients producer Tiba

Private equity firm Amethis has entered into definitive agreements for a significant minority investment in Tiba for Starch & Glucose, an Egyptian producer of rice-based specialty food ingredients.

5. SPE Capital-led consortium invests in Egypt’s Orchidia Pharmaceutical Industries

A consortium led by SPE Capital has completed an investment in Orchidia Pharmaceutical Industries, an Egyptian manufacturer of eye-care medicines. The investment was made through SPE Capital’s Private Equity Fund III and includes the European Bank for Reconstruction and Development, Proparco, and the Belgian Investment Company for Developing Countries.

Access the Dealmaker’s Log May 2026 below:

Keep reading with a 7-day free trial

Subscribe to Africa Private Equity News to keep reading this post and get 7 days of free access to the full post archives.

Start trialAlready a paid subscriber? Sign inPreviousNext
Premium Times Nigeria

Ebola: Saudi Arabia suspends travel to Kenya, halts visa issuance

The Saudi Press Agency (SPA) announced the measures in a statement published on its official X account on Friday, 30 October, saying they followed epidemiological assessments by the country’s health authorities The post Ebola: Saudi Arabia suspends travel to Kenya, halts visa…

Ebola: Saudi Arabia suspends travel to Kenya, halts visa issuance
Premium Times Nigeria

Group seeks end to health workers’ absenteeism in PHCs

“Our expectation is that the government and other policymakers will take renewed action to ensure that these interventions are implemented across the state,” the group's coordinator said. The post Group seeks end to health workers’ absenteeism in PHCs appeared first on Premium…

Group seeks end to health workers’ absenteeism in PHCs